rs4293393 — UMOD
UMOD promoter variant affecting uromodulin expression, linked to CKD, salt-sensitive hypertension, and gout risk with paradoxical kidney stone protection
Details
- Gene
- UMOD
- Chromosome
- 16
- Risk allele
- A
- Consequence
- Regulatory
- Inheritance
- Additive
- Clinical
- Risk Factor
- Evidence
- Established
- Chip coverage
- v3 v4 v5
Population Frequency
Ancestry Frequencies
Related SNPs
Category
Nutrition & MetabolismSee your personal result for UMOD
Upload your DNA data to find out which genotype you carry and what it means for you.
Upload your DNA dataWorks with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.
UMOD Promoter Variant — When Kidney Protection Comes at a Cost
The UMOD gene encodes uromodulin11 uromodulin
Also called Tamm-Horsfall protein, uromodulin is the most abundant protein in normal human urine, produced exclusively by cells lining the thick ascending limb of the loop of Henle, a protein with a paradoxical dual role in kidney health. Uromodulin forms protective filaments in urine that trap bacteria and prevent urinary tract infections22 trap bacteria and prevent urinary tract infections
Uromodulin polymerizes into filaments that bind type 1 fimbriae on uropathogenic E. coli, blocking their attachment to the bladder wall, but it also activates sodium reabsorption in the kidney, driving up blood pressure. The rs4293393 variant sits in the UMOD promoter region33 UMOD promoter region
Located 550 base pairs upstream of the transcription start site, within a glucocorticoid response element, where it controls how much uromodulin your kidneys produce — and more is not always better.
The Mechanism
The rs4293393 risk allele (A on the plus strand, reported as T in the medical literature since UMOD is on the minus strand) sits within a glucocorticoid response element44 glucocorticoid response element
A DNA sequence where glucocorticoid receptor proteins bind to regulate gene transcription in the UMOD promoter. The risk allele approximately doubles promoter activity55 doubles promoter activity
Luciferase reporter assays showed ~2-fold higher transcription with the risk allele across multiple kidney cell lines compared to the protective G allele, leading to higher uromodulin production. This excess uromodulin activates the NKCC2 sodium-potassium-chloride cotransporter66 NKCC2 sodium-potassium-chloride cotransporter
The key sodium reabsorption channel in the thick ascending limb of the loop of Henle, activated via SPAK/OSR1 kinase signaling in the thick ascending limb of the loop of Henle, increasing sodium reabsorption and driving salt-sensitive hypertension. The same mechanism causes progressive kidney damage through sustained hemodynamic stress on nephrons.
The Evidence
The UMOD promoter locus is one of the strongest and most replicated GWAS signals for kidney function. A landmark Icelandic study77 landmark Icelandic study
Gudbjartsson et al. PLoS Genetics 2010 — 3,203 CKD cases and 38,782 controls from deCODE found the risk allele conferred CKD susceptibility with OR 1.25 (P = 4.1 x 10⁻¹⁰), while paradoxically protecting against kidney stones (OR 0.88, P = 5.7 x 10⁻⁵). A critical finding was that the effect on serum creatinine is strongly age-dependent88 strongly age-dependent
Negligible before age 50 but accelerating rapidly after, at ~0.09 μmol/L per allele per year — negligible before age 50 but increasing sharply thereafter, particularly in the presence of comorbidities like diabetes and hypertension.
The Framingham Heart Study99 Framingham Heart Study
Köttgen et al. JASN 2010 — 200 FHS participants with uromodulin measurements and genotyping demonstrated a striking dose-response: urinary uromodulin concentrations were 5.5 μg/mL with two risk alleles versus just 1.5 μg/mL with two protective alleles, and elevated uromodulin preceded incident CKD (OR 1.72 per SD increase).
The largest study to date, a PheWAS in 648,593 veterans1010 PheWAS in 648,593 veterans
Hung et al. Kidney Int Rep 2022 — Million Veteran Program multiethnic biobank from the Million Veteran Program, confirmed CKD risk (OR 1.22), hypertension (OR 1.03), gout (OR 1.04), and demonstrated protective effects against UTIs (OR 0.94) and kidney stones (OR 0.85) — all in non-Hispanic White participants. Notably, these associations were absent or attenuated in Black participants.
Practical Implications
The UMOD risk allele is extraordinarily common — carried by approximately 80% of people of European and African ancestry and over 90% in East Asian populations. This high frequency is maintained by pathogen-driven natural selection1111 pathogen-driven natural selection
Olden et al. JASN 2016 — analysis of 156 worldwide populations showed UMOD risk allele frequency correlates with bacterial diversity and UTI-causing pathogen prevalence: the same allele that increases CKD risk also protects against urinary tract infections, a major cause of morbidity throughout human evolution. The protective allele was found in Neanderthal and Denisovan genomes but has been selected against in modern humans, likely because UTI protection was more immediately advantageous than avoiding late-onset kidney disease.
The strongly age-dependent effect means this variant matters most after age 50, especially in the context of other metabolic risk factors. The mechanism through NKCC2 activation makes this a genuinely salt-sensitive form of hypertension — carriers may respond specifically to loop diuretics1212 loop diuretics
Studies showed the loop diuretic furosemide produced greater blood pressure reduction and natriuresis in homozygous risk carriers compared to non-carriers and sodium restriction.
Interactions
rs4293393 is in near-perfect linkage disequilibrium1313 near-perfect linkage disequilibrium
r² = 0.95–1.0 in HapMap CEU populations with rs12917707, meaning these two SNPs are effectively the same signal — a person's genotype at one nearly always predicts their genotype at the other. Both tag the same UMOD promoter haplotype. rs13333226 is another SNP in the same LD block with concordant effects on uromodulin expression and CKD risk.
The UMOD mechanism intersects with other kidney function pathways. Variants in SLC22A2 (organic cation transporter, relevant to metformin clearance), SLC34A1 (phosphate transport), and APOL1 (African-ancestry CKD risk) affect kidney function through independent mechanisms and could compound CKD risk when present alongside the UMOD risk allele.
Genotype Interpretations
What each possible genotype means for this variant:
Two protective alleles — lowest uromodulin expression with reduced CKD and hypertension risk
You have two copies of the protective allele, producing the lowest uromodulin levels. Your kidneys reabsorb less sodium through NKCC2, conferring natural resistance to salt-sensitive hypertension and reducing your CKD risk by approximately 20% compared to AA carriers. Only about 3% of people of European ancestry share this uncommon genotype. The trade-off is slightly reduced innate defense against urinary tract infections, since uromodulin filaments are your primary urinary antibacterial mechanism.
One copy of the UMOD promoter risk allele — moderately elevated uromodulin with intermediate CKD risk
The AG genotype produces intermediate urinary uromodulin concentrations (~3.1 μg/mL in the Framingham Heart Study, between the 5.5 μg/mL of AA and 1.5 μg/mL of GG carriers). The additive inheritance pattern means your NKCC2-mediated sodium reabsorption is modestly elevated but not maximally driven. Your CKD risk increase is approximately half that of AA carriers (~11% increased risk per the MVP additive model). You retain partial UTI protection from uromodulin while having a smaller burden of salt-sensitive blood pressure elevation.
Two copies of the UMOD promoter risk allele — highest uromodulin expression, greatest CKD and hypertension risk
The AA genotype produces approximately 3.5-fold higher urinary uromodulin concentrations compared to GG carriers (5.5 vs 1.5 μg/mL in the Framingham Heart Study). This excess uromodulin activates NKCC2 sodium channels via SPAK/OSR1 kinase signaling, increasing sodium reabsorption in the thick ascending limb. The resulting volume expansion drives salt-sensitive hypertension and progressive nephron damage.
In the Million Veteran Program (648,593 veterans), each copy of this allele increased CKD risk by 22% (OR 1.22). The Icelandic deCODE study found the effect on serum creatinine was negligible before age 50 but accelerated rapidly thereafter at ~0.09 μmol/L per allele per year, compounding with comorbidities. This means the variant behaves as a vulnerability factor — it weakens the kidney's ability to withstand age-related metabolic stress rather than directly causing disease in young, healthy individuals.
Key References
Hung et al. (2022, Kidney Int Rep): MVP PheWAS of 648,593 veterans — CKD OR 1.22, kidney stone OR 0.85, UTI OR 0.94 for risk allele in White population
Trudu et al. (2013, Nat Med): Risk variant doubles UMOD promoter activity and uromodulin expression; transgenic overexpression causes salt-sensitive hypertension via NKCC2 activation
Gudbjartsson et al. (2010, PLoS Genet): CKD OR 1.25 in 3,203 Icelandic cases; effect on serum creatinine increases with age (negligible before 50, accelerates after)
Köttgen et al. (2010, JASN): Urinary uromodulin 5.5 vs 1.5 μg/mL by genotype in FHS; elevated uromodulin precedes incident CKD (OR 1.72 per SD)
Olden et al. (2016, JASN): UMOD risk allele maintained at 80% frequency by pathogen-driven selection — uromodulin protects against UTIs and correlates with bacterial diversity across 156 populations